Inventor · disambiguated record
G. Franz
Also filed as: FRANZ G A · FRANZ G ANDREW
3 granted patents·27 pending applications·102 citations·filing 2002–2007
74Inventor score
Top patents by PatentIndex Score
30 records- 0189US6555581B1Levothyroxine compositions and methodsJONES PHARMA INC·Filed 2002·Granted Apr 29, 2003·73 cites·25 claims
- 0277US7067148B2Stabilized pharmaceutical and thyroid hormone compositions and method of preparationKING PHARMACEUTICAL RES & DEV·Filed 2002·Granted Jun 27, 2006·14 cites·24 claims
- 0373US7101569B2Methods of administering levothyroxine pharmaceutical compositionsFRANZ G ANDREW·Filed 2002·Granted Sep 5, 2006·15 cites·3 claims
- 0455US2003180356A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 0555US2003171436A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 0655US2003190350A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 0755US2003181524A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 0855US2003190359A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 0955US2003175337A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 1055US2003165564A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 1155US2004043066A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 1255US2003191185A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 1351US2003224047A1Levothyroxine compositions and methodsFiled 2003·Application pending·0 cites
- 1447US2003195253A1Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administrationFiled 2002·Application pending·0 cites
- 1547US2003198668A1Levothyroxine pharmaceutical compositions, methods of making and methods of administrationFiled 2002·Application pending·0 cites
- 1646US2008003284A1Levothyroxine compositions and methosFRANZ G A·Filed 2007·Application pending·0 cites
- 1743US2003195254A1Levothyroxine compositions having unique triiodothyronine Tmax propertiesFiled 2002·Application pending·0 cites
- 1843US2003194437A1Levothyroxine compositions having unique triiodothyronine Cmax propertiesFiled 2002·Application pending·0 cites
- 1942US2003032675A1Manufacture of thyroid hormone tablets having consistent active moiety amountsFiled 2002·Application pending·0 cites
- 2041US2003198672A1Levothyroxine compositions having unique triidothyronine plasma AUC propertiesFiled 2002·Application pending·0 cites
- 2141US2003198671A1Levothyroxine compositions having unique plasma AUC propertiesFiled 2002·Application pending·0 cites
- 2241US2003190349A1Methods of stabilizing pharmaceutical compositionsFiled 2002·Application pending·0 cites
- 2341US2003185885A1Non-granulated levothyroxine pharmaceutical compositionsFiled 2002·Application pending·0 cites
- 2441US2003203967A1Levothyroxine compositions having unique Tmax propertiesFiled 2002·Application pending·0 cites
- 2541US2003199586A1Unique levothyroxine aqueous materialsFiled 2002·Application pending·0 cites
- 2641US2003199587A1Levothyroxine compositions having unique Cmax propertiesFiled 2002·Application pending·0 cites
- 2741US2003180353A1Stabilized pharmaceutical compositionsFiled 2002·Application pending·0 cites
- 2839US2003199585A1Levothyroxine compositions and methodsFRANZ G ANDREW·Filed 2002·Application pending·0 cites
- 2938US2003203968A1Levothyroxine compositions and methodsFiled 2003·Application pending·0 cites
- 3035US2003199588A1Levothyroxine compositions and methodsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when G. Franz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →